BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9366673)

  • 21. Enzymatic sulfation of galactose residue of keratan sulfate by chondroitin 6-sulfotransferase.
    Habuchi O; Hirahara Y; Uchimura K; Fukuta M
    Glycobiology; 1996 Jan; 6(1):51-7. PubMed ID: 8991509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allelic heterogeneity of the carbohydrate sulfotransferase-6 gene in patients with macular corneal dystrophy.
    Sultana A; Sridhar MS; Klintworth GK; Balasubramanian D; Kannabiran C
    Clin Genet; 2005 Nov; 68(5):454-60. PubMed ID: 16207214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focus on molecules: CHST6 (carbohydrate sulfotransferase 6; corneal N-acetylglucosamine-6-sulfotransferase).
    Musselmann K; Hassell JR
    Exp Eye Res; 2006 Oct; 83(4):707-8. PubMed ID: 16549065
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases.
    Funderburgh JL; Funderburgh ML; Rodrigues MM; Krachmer JH; Conrad GW
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):419-28. PubMed ID: 2138589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and characterization of human keratan sulfate Gal-6-sulfotransferase.
    Fukuta M; Inazawa J; Torii T; Tsuzuki K; Shimada E; Habuchi O
    J Biol Chem; 1997 Dec; 272(51):32321-8. PubMed ID: 9405439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective processing of keratan sulfate in macular corneal dystrophy.
    Nakazawa K; Hassell JR; Hascall VC; Lohmander LS; Newsome DA; Krachmer J
    J Biol Chem; 1984 Nov; 259(22):13751-7. PubMed ID: 6238957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycosyltransferase and sulfotransferase activities in chick corneal stromal cells before and after in vitro culture.
    Nakazawa K; Takahashi I; Yamamoto Y
    Arch Biochem Biophys; 1998 Nov; 359(2):269-82. PubMed ID: 9808769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I.
    Lewis D; Davies Y; Nieduszynski IA; Lawrence F; Quantock AJ; Bonshek R; Fullwood NJ
    Glycobiology; 2000 Mar; 10(3):305-12. PubMed ID: 10704529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
    Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
    Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.
    Sultana A; Klintworth GK; Thonar EJ; Vemuganti GK; Kannabiran C
    Mol Vis; 2009; 15():319-25. PubMed ID: 19204788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities of proteoglycans and glycoproteins synthesized by corneal organ cultures derived from patients with macular corneal dystrophy.
    Klintworth GK; Smith CF
    Lab Invest; 1983 May; 48(5):603-12. PubMed ID: 6601743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic synthesis in vitro of the disulfated disaccharide unit of corneal keratan sulfate.
    Akama TO; Misra AK; Hindsgaul O; Fukuda MN
    J Biol Chem; 2002 Nov; 277(45):42505-13. PubMed ID: 12218059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing.
    Quantock AJ; Meek KM; Ridgway AE; Bron AJ; Thonar EJ
    Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glycosaminoglycans associate with corneal transparency].
    Li Y; Yi Y; Feng G; Zheng H; Lin J
    Yan Ke Xue Bao; 1991 Jun; 7(2):58-62. PubMed ID: 1844058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes responsible for synthesis of corneal keratan sulfate glycosaminoglycans.
    Kitayama K; Hayashida Y; Nishida K; Akama TO
    J Biol Chem; 2007 Oct; 282(41):30085-96. PubMed ID: 17690104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea.
    Di Iorio E; Barbaro V; Volpi N; Bertolin M; Ferrari B; Fasolo A; Arnaldi R; Brusini P; Prosdocimo G; Ponzin D; Ferrari S
    Exp Eye Res; 2010 Aug; 91(2):293-9. PubMed ID: 20537995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, photoaffinity labeling, and characterization of a single enzyme for 6-sulfation of both chondroitin sulfate and keratan sulfate.
    Sugumaran G; Katsman M; Drake RR
    J Biol Chem; 1995 Sep; 270(38):22483-7. PubMed ID: 7673238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations of the carbohydrate sulfotransferase-6 (CHST6) gene causing macular corneal dystrophy in India.
    Sultana A; Sridhar MS; Jagannathan A; Balasubramanian D; Kannabiran C; Klintworth GK
    Mol Vis; 2003 Dec; 9():730-4. PubMed ID: 14735064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene.
    Akama TO; Nishida K; Nakayama J; Watanabe H; Ozaki K; Nakamura T; Dota A; Kawasaki S; Inoue Y; Maeda N; Yamamoto S; Fujiwara T; Thonar EJ; Shimomura Y; Kinoshita S; Tanigami A; Fukuda MN
    Nat Genet; 2000 Oct; 26(2):237-41. PubMed ID: 11017086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty.
    Küchle M; Cursiefen C; Fischer DC; Schlötzer-Schrehardt U; Naumann GO
    Arch Ophthalmol; 1999 Apr; 117(4):528-31. PubMed ID: 10206585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.